- ￥1668
- abinScience
- China
- HF645014
- 2026年03月03日
- ELISA, IHC, WB
- Rabbit
- Human
企业认证
相关产品推荐更多 >
Anti-Shank1 and Shank3 Antibody (N367/51), 抗Shank1and Shank3抗体 (N367/51)
￥1176Anti-GRK2 Polyclonal Antibody, 抗GRK2多克隆抗体
￥1008
Research Grade Lintuzumab, 研究级Lintuzumab
￥2288
Anti-VCAN Polyclonal Antibody, 抗VCAN多克隆抗体
询价Research Grade Anti-Human TPBG/5T4 Antibody (825c), Research Grade Anti-Human TPBG/5T4抗体 (825c)
￥2588
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Rabbit
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Rabbit
- 目录编号：
HF645014
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Rabbit
- 应用范围：
ELISA, IHC, WB
- 浓度：
1mg/mL
- 靶点：
Cytotoxic and regulatory T-cell molecule; Class-I MHC-restricted T-cell-associated molecule; CD355; CRTAM
- 抗体英文名：
Anti-Human CRTAM Polyclonal Antibody
- 抗体名：
Anti-Human CRTAM Polyclonal Antibody
- 规格：
100ul
| Product name | Anti-Human CRTAM Polyclonal Antibody |
|---|---|
| Catalog No. | HF645014 |
| Host species | Rabbit |
| Species reactivity | Human |
| Immunogen | E. coli - derived recombinant human CRTAM (Ser18-Val218). |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Purity | / |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA, IHC, WB |
| Target | Cytotoxic and regulatory T-cell molecule; Class-I MHC-restricted T-cell-associated molecule; CD355; CRTAM |
| Purification | Purified by antigen affinity column. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | O95727 |
| Alternative Names | / |
| Clone ID | / |
| Species | / |
| Product Usage Information | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation., PMID:38867048
• Current understanding of CTLA-4: from mechanism to autoimmune diseases., PMID:37497212
• Extremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging., PMID:37126417
• Regulatory T cells in cancer immunosuppression - implications for anticancer therapy., PMID:30705439
• CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer., PMID:37507075
• Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?, PMID:31102428
• Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases., PMID:34276700
• Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells., PMID:38486310
• Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells., PMID:34301886
Polyclonal and Monoclonal Antibodies in Clinic
, almost any organic chemical induces antibody production of antibodies that would bind specifically to the chemical. These antibodies are often produced from multiple B cell clones and referred to as polyclonal antibodies. In recent years, scientists have exploited
. A rabbit polyclonal antisera is also available (101c500; BAbCO) but in our hands this was less reactive. The antibody cleanup protocol is now a seperate document Protocol Cells are grown in 5 mls of YPAD to an O.D. 600 of 0.75 to 1.
suspended in PBS. A rabbit polyclonal antisera is also available (101c500; BAbCO) but in our hands this was less reactive. The antibody cleanup protocol is now a seperate document Protocol Cells are grown in 5 mls of YPAD to an O.D. 600
技术资料暂无技术资料 索取技术资料
